Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

TRK 820

Known as: TRK-820 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
In atopic dermatitis patients, pruritus is a severe symptom that is difficult to treat. It is previously reported that TRK-820, a… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Salvinorin A, TRK-820 (17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-[N-methyl-trans-3-(3-furyl) acrylamido]morphinan… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
2004
2004
The inhibitory effects of kappa-opioid receptor agonists on systemic skin scratching induced by the intravenous administration of… Expand
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The effects of the kappa-opioid receptor agonist, TRK-820, (-)-17-(cyclopropylmethyl)-3, 14beta-dihydroxy-4, 5alpha-epoxy-6beta… Expand
Is this relevant?
2002
2002
Abstract.Rationale: We previously demonstrated that the prototypical κ-opioid receptor agonist U-50,488H did not affect the… Expand
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
2001
2001
The effects of the novel kappa-opioid receptor agonist TRK-820 on the rewarding and locomotor-enhancing effects of morphine were… Expand
Is this relevant?
2000
2000
We have already reported that TRK-820, (-)-17-cyclopropylmethyl-3, 14b-dihydroxy-4, 5a-epoxy-6b-[N-methyl-trans-3-(3-furyl… Expand
Is this relevant?
2000
2000
The effects of a novel kappa-opioid receptor agonist, TRK-820, on the development of physical dependence on morphine were… Expand
Is this relevant?
1999
1999
TRK-820, a new type of 4,5-epoxymorphinan derivative, was investigated in vivo for antinociceptive activities and its selectivity… Expand
Is this relevant?
1999
1999
We analyzed the pharmacological properties of 17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-6b eta-[N-methyl-trans-3-(3… Expand
Is this relevant?